两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 8-K/A [Amend] Current report, items 5.02 and 9.01 Accession Number: 0001829126-24-003876 Act: 34 Size: 218 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001829126-24-003748 Act: 34 Size: 223 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001829126-24-003657 Act: 34 Size: 329 KB 网页链接
$OpGen(OPGN)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001829126-24-003485 Act: 34 Size: 43 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 3.03, 5.03, 5.07, and 9.01 Accession Number: 0001829126-24-003340 Act: 34 Size: 335 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001829126-24-002907 Act: 34 Size: 299 KB 网页链接
$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001829126-24-002814 Act: 34 Size: 457 KB 网页链接
$OpGen(OPGN)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001829126-24-002786 Act: 34 Size: 37 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000949 Size: 7 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001829126-24-002784 Act: 34 Size: 264 KB 网页链接